Clinical Trials Logo

Vocal Cord Dysfunction clinical trials

View clinical trials related to Vocal Cord Dysfunction.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05770518 Active, not recruiting - Clinical trials for Vocal Cord Dysfunction

Biofeedback vs Laryngeal Control Therapy in Management of Paradoxical Vocal Fold Motion

Start date: March 7, 2023
Phase: N/A
Study type: Interventional

Paradoxical Vocal Fold Motion (PVFM) is a condition where vocal cords adduct (move toward another) instead of abduct (move away from one another) during inspiration, thus causing shortness of breath. The goal of this pilot randomized controlled trial is to compare the efficacy of biofeedback as compared to laryngeal control therapy (LCT) in the treatment of PVFM. Participants will take surveys about their symptoms and their expectations of treatment prior to initiating treatment and after completion of their assigned treatment. Researchers will compare the biofeedback group to the LCT group to see if participants have differences in changes of their symptoms.

NCT ID: NCT05246930 Active, not recruiting - Asthma Clinical Trials

Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma

Start date: June 15, 2022
Phase:
Study type: Observational

This study will determine if airway resistance to airflow and pressure, measured by Impulse Oscillometry, is impacted in subjects with vocal cord disorders and whether these measurements are different when compared to subjects with asthma.

NCT ID: NCT04593394 Active, not recruiting - Asthma Chronic Clinical Trials

Inducible Laryngeal Obstruction in Severe Asthma in Severe Asthma

Start date: November 1, 2020
Phase:
Study type: Observational

The first part will be a comparative cross-sectional study to identify the frequency of ILO and other comorbidites among participants with asthma compared to a group of reference subjects without asthma, matched for age- and gender and race. The second part will be a longitudinally observational study study following participants for one year after the cross-sectional study. The Maat-scores ILO-symptoms and asthma-outcomes longitudinally will be evaluated, .